VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival
Cancer Immunology, Immunotherapy May 16, 2018
Kuklinski LF, et al. - Given adaptive immune responses contribute to the pathogenesis of melanoma by facilitating immune evasion. researchers determined the association between expression of VISTA (V-domain Ig suppressor of T-cell activation; a potent negative regulator of T-cell function, expressed at high levels on monocytes, granulocytes, and macrophages, and at lower densities on T-cell populations within the tumor microenvironment) on tumor-infiltrating inflammatory cells and survival in primary cutaneous melanoma using Pearson’s correlation coefficients. In univariate and multivariate analysis, the presence of VISTA was found to be related to a significantly worse disease-specific survival. Overall, VISTA expression was identified as an independent negative prognostic factor in primary cutaneous melanoma and its potential as an adjuvant immunotherapeutic intervention in the future was suggested.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries